AmerisourceBergen (now Cencora) is a major American pharmaceutical services company formed by the 2001 merger of AmeriSource and Bergen Brunswig. The company has grown through acquisitions, faced opioid litigation, and rebranded as Cencora in 2023.
Emil Buergin and Joseph Brunswig establish Bergen Brunswig Drug Company in Los Angeles, California, initially a wholesale drug distributor. #history #pharmaceuticals
Bergen Brunswig formally incorporates as a wholesaler of pharmaceuticals and healthcare products, expanding its distribution network across the western United States. #business #pharmaceuticals
Suburban Drug Company is founded in Pennsylvania, which later becomes AmeriSource Health Corporation. The company focuses on pharmaceutical distribution to independent pharmacies. #history #pharmaceuticals
Bergen Brunswig holds its initial public offering (IPO) on the New York Stock Exchange under the ticker BBC, raising capital for expansion. #finance #ipo
Bergen Brunswig acquires Durr Drug Company, a regional wholesaler, strengthening its presence in the southeastern United States. #acquisition #pharmaceuticals
Bergen Brunswig expands into healthcare services by acquiring HealthCare Services, a medical-surgical supply distributor. #acquisition #healthcare
Suburban Drug Company changes its name to AmeriSource Health Corporation to reflect its national ambitions. #rebranding #pharmaceuticals
Bergen Brunswig acquires Durr-Fillauer Medical for $225 million, expanding its surgical and medical supply business. #acquisition #medical
AmeriSource Health Corporation launches its IPO on the New York Stock Exchange, raising funds to compete with larger wholesalers. #finance #ipo
Bergen Brunswig enters the diagnostic imaging market with the acquisition of Diagnostic Imaging Inc. #acquisition #imaging
Bergen Brunswig acquires PharMark, a pharmacy benefit management company, to expand into PBM services. #acquisition #pharmacy
The newly merged company begins trading on the NYSE under the ticker ABC, with headquarters in Valley Forge, Pennsylvania. #stockmarket #pharmaceuticals
AmeriSource Health Corporation and Bergen Brunswig Corporation merge to form AmerisourceBergen Corporation, creating one of the largest pharmaceutical wholesalers in the world. #merger #pharmaceuticals
R. David Yost becomes CEO of AmerisourceBergen, leading the company through post-merger integration and growth. #leadership #ceo
AmerisourceBergen acquires IVAX Pharmaceuticals, a generic drug manufacturer, for about $1.8 billion to expand its manufacturing capabilities. #acquisition #genericdrugs
The company settles SEC charges related to accounting irregularities from 1999-2002, paying $10 million in fines. #legal #accounting
AmerisourceBergen acquires Bridge Medical, a provider of medication safety and barcode technology, to enhance patient safety solutions. #acquisition #healthIT
AmerisourceBergen launches the Good Neighbor Pharmacy (GNP) network to support independent pharmacies with purchasing power and marketing. #pharmacy #retail
Acquisition of Metro Medical, a medical-surgical supply distributor, expanding its alternate site care business. #acquisition #medical
Berkshire Hathaway, led by Warren Buffett, discloses a 1.7% stake in AmerisourceBergen, signaling investor confidence. #investment #buffett
AmerisourceBergen acquires World Courier, a global specialty logistics provider, to expand international clinical trial supply chain services. #acquisition #logistics
Steven H. Collis is appointed CEO of AmerisourceBergen, succeeding R. David Yost. Collis later leads the company through major transformations. #leadership #ceo
AmerisourceBergen acquires Integrated Commercialization Solutions, enhancing its services for pharmaceutical manufacturers. #acquisition #pharma
AmerisourceBergen enters a 10-year strategic agreement with Walgreens Boots Alliance, making Walgreens a major customer and investor. #partnership #retail
AmerisourceBergen acquires PharMEDium Healthcare, a provider of outsourced compounding pharmacy services, for $450 million. #acquisition #pharmacy
AmerisourceBergen combines its patient access and reimbursement services into Lash Group, a leading patient support services provider. #services #healthcare
Acquisition of Censeo Health, a company specializing in comprehensive medication management, expanding clinical services. #acquisition #clinical
AmerisourceBergen faces first lawsuits from states and municipalities alleging role in the opioid epidemic. The company is accused of failing to report suspicious orders. #legal #opioid
AmerisourceBergen acquires H. D. Smith, a large pharmaceutical wholesaler, for $815 million, consolidating the wholesale market. #acquisition #wholesale
Walgreens Boots Alliance acquires a minority stake in AmerisourceBergen's specialty pharmacy business, enhancing their collaboration. #investment #specialty
AmerisourceBergen plays a key role in distributing COVID-19 vaccines and treatments under Operation Warp Speed, leveraging its logistics network. #covid19 #vaccine
AmerisourceBergen agrees to pay up to $6.1 billion to settle opioid-related lawsuits, with payments distributed over 18 years. #legal #settlement
AmerisourceBergen acquires Alliance Healthcare from Walgreens Boots Alliance for $6.5 billion, expanding its European operations. #acquisition #europe
AmerisourceBergen acquires PharmaLex, a global consulting and services provider to the pharmaceutical industry, strengthening its consulting arm. #acquisition #consulting
Cencora's stock begins trading on the NYSE under the new ticker COR, marking the corporate identity change. #stockmarket #cencora
AmerisourceBergen rebrands as Cencora, unveiling a new name and logo to reflect its evolution into a global healthcare solutions company. #rebranding #cencora
Cencora acquires C2DX, a leading cell and gene therapy logistics provider, enhancing its specialty logistics capabilities. #acquisition #genetherapy
Cencora announces fiscal 2024 revenue of $256 billion, driven by growth in specialty and international segments. #finance #revenue
Cencora announces expansion into the Asia-Pacific region through partnerships and acquisitions, targeting emerging markets. #expansion #asia